Georgia Institute of Technology Mar 4 2026 The Georgia Institute of Technology has been awarded up to $21.8 million from the Advanced Research Projects Agency for Health (ARPA-H) to deliver a first-of-its-kind therapy to patients with lymphatic disease. For many of these patients, care has long meant pain and disfigurement alongside other severe side effects, rather than receiving treatment that addresses the disease itself. This new ARPA-H award marks a potential turning point. Lead researcher